|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the University of British Columbia, McDonald Research Laboratories/The iCAPTURE Centre, Vancouver, BC, Canada.
Correspondence to: Keith R. Walley, MD, McDonald Research Laboratories/The iCAPTURE Centre, Providence Health Care/University of British Columbia, 1081 Burrard St, Vancouver, BC Canada V6Z 1Y6; e-mail: kwalley{at}mrl.ubc.ca
Genetic epidemiologic studies suggest a strong genetic influence on the outcome from sepsis, and genetics may explain the wide variation in the individual response to infection that has long puzzled clinicians. Several candidate genes have been identified as important in the inflammatory response and investigated in case-controlled studies, including the tumor necrosis factor (TNF)-
and TNF-ß genes, positioned next to each other within the cluster of human leukocyte antigen class III genes on chromosome 6. Other candidate genes for sepsis and septic shock include the interleukin (IL)-1 receptor antagonist gene, the heat shock protein gene, the IL-6 gene, the IL-10 gene, the CD-14 gene, the Toll-like receptor (TLR)-4 gene, and the TLR-2 gene, to name a few. In this review, we summarize the evidence for a genetic susceptibility to development of sepsis and death from sepsis, discuss design of clinical genetics studies relevant to the study of complex disorders, consider the candidate genes likely to be involved in the pathogenesis of sepsis, and discuss the potential for targeted therapy of sepsis and septic shock based on genetic variability.
Key Words: heat-shock proteins interleukins polymorphism septicemia sepsis syndrome tumor necrosis factor
This article has been cited by other articles:
![]() |
L. Romics Jr, G. Szabo, J. C. Coffey, J. H. Wang, and H. P. Redmond The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases Arch Surg, June 1, 2006; 141(6): 595 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sipahi, H. Pocan, and N. Akar Effect of Various Genetic Polymorphisms on the Incidence and Outcome of Severe Sepsis Clinical and Applied Thrombosis/Hemostasis, January 1, 2006; 12(1): 47 - 54. [Abstract] [PDF] |
||||
![]() |
R. G. Wunderink Nosocomial Pneumonia, Including Ventilator-associatedPneumonia Proceedings of the ATS, December 1, 2005; 2(5): 440 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Blackwell, S. M. Moscovis, A. E. Gordon, O. M. Al Madani, S. T. Hall, M. Gleeson, R. J. Scott, J. Roberts-Thomson, D. M. Weir, and A. Busuttil Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors J. Leukoc. Biol., December 1, 2005; 78(6): 1242 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Carrigan, G. Scott, and M. Tabrizian Toward Resolving the Challenges of Sepsis Diagnosis Clin. Chem., August 1, 2004; 50(8): 1301 - 1314. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |